For research use only. Not for therapeutic Use.
GCN2-IN-1 (A-92) is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with an IC50 of <0.3 μM in the enzyme assay and an IC50 of 0.3-3 μM in the cell assay[1].<br>GCN2-IN-1 (Compound A-92) is a GCN2 inhibitor, which may be useful as a chemotherapeutic drug for the treatment of cancer[1].
Catalog Number | I020177 |
CAS Number | 1448693-69-3 |
Molecular Formula | C₁₉H₁₈N₁₀O |
Purity | ≥95% |
Target | Eukaryotic Initiation Factor (eIF) |
Reference | [1]. Dieter Dorsch, et al. Triazolo[4,5-d]pyrimidine derivatives. WO2013110309A1. |